Characteristics of folliculogenesis, steroidogenesis, and oogenesis during ovarian stimulation in the luteal phase of the menstrual cycle
- Authors: Korneeva I.E.1, Martirosyan Y.O.1, Koval’chuk A.I.1, Nazarenko T.A.1, Biryukova A.M.1, Veyukova M.A.1, Ivanets T.Y.1
-
Affiliations:
- V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia
- Issue: No 7 (2021)
- Pages: 107-112
- Section: Articles
- URL: https://journals.eco-vector.com/0300-9092/article/view/249392
- DOI: https://doi.org/10.18565/aig.2021.7.107-112
- ID: 249392
Cite item
Abstract
Full Text
About the authors
Irina E. Korneeva
V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia
Email: irina.korneeva@inbox.ru
Dr. Med. Sci., Professor, Senior Researcher at the F. Paulsen Research and Educational Center for ART with the Clinical Department
Yana O. Martirosyan
V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia
Email: ya_martirosyan@oparina4.ru
Junior Researcher at the F. Paulsen Research and Educational Center for ART with the Clinical Department
Alla I. Koval’chuk
V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia
Email: kovalchukalla27@mail.ru
Ph.D. Student
Tatiana A. Nazarenko
V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia
Email: t_nazarenko@oparina4.ru
Dr. Med. Sci., Professor, Head of the Institute of Reproductive Medicine
Almina M. Biryukova
V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia
Email: a_birukova@oparina4.ru
Ph.D (Med. Sci.), Clinical Supervisor at the F. Paulsen Research and Educational Center for ART with the Clinical Department
Mariya A. Veyukova
V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia
Email: veymary@gmail.com
Ph.D (Bio. Sci.), Head of the Embryological Laboratory, F. Paulsen Research and Educational Center for ART with the Clinical Department
Tatiana Yu. Ivanets
V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia
Email: t_ivanets@oparina4.ru
Dr. Med. Sci., Head of the Clinical Diagnostic Laboratory
References
- Baerwald A.R., Adams G.P., Pierson R.A. A new model for ovarian follicular development during the human menstrual cycle. Fertil. Steril. 2003; 80(1): 116 22. https://dx.doi.org/10.1016/s0015-0282(03)00544-2
- Baerwald A.R., Adams G.P., Pierson R.A. Characterization of ovarian follicular wave dynamics in women. Biol. Reprod. 2003; 69(3): 1023-31. https://dx.doi.org/10.1095/biolreprod.103.017772.
- Kuang Y., Chen Q., Hong Q., Lyu Q., Ai A., Fu Y., Shoham Z. Double stimulations during the follicular and luteal phases of poor responders in IVF/ ICSI programmes (Shanghai protocol). Reprod. Biomed. Online. 2014; 29(6): 684-91. https://dx.doi.org/10.1016/j.rbmo.2014.08.009.
- Cakmak H., Katz A., Cedars M.I., Rosen M.P. Effective method for emergency fertility preservation: random-start controlled ovarian stimulation. Fertil. Steril. 2013; 100(6): 1673-80. https://dx.doi.org/10.1016/j.fertnstert.2013.07.1992.
- von Wolff M., Thaler C.J., Frambach T., Zeeb C., Lawrenz B., Popovici R.M., Strowitzki T. Ovarian stimulation to cryopreserve fertilized oocytes in cancer patients can be started in the luteal phase. Fertil. Steril. 2009; 92(4): 1360-5. https://dx.doi.org/10.1016/j.fertnstert.2008.08.011.
- Kim J.H., Kim S.K., Lee H.J., Lee J.R., Jee B.C., Suh C.S., Kim S.H. Efficacy of random-start controlled ovarian stimulation in cancer patients. J. Korean Med. Sci. 2015; 30(3): 290-5. https://dx.doi.org/10.3346/jkms.2015.30.3.290.
- Muteshi C., Child T., Ohuma E., Fatum M. Ovarian response and follow-up outcomes in women diagnosed with cancer having fertility preservation: Comparison of random start and early follicular phase stimulation - cohort study. Eur. J. Obstet. Gynecol. Reprod. Biol. 2018; 230: 10-4. https://dx.doi.org/10.1016/j.ejogrb.2018.09.007.
- Wei L.H., Ma W.H., Tang N., Wei J.H. Luteal-phase ovarian stimulation is a feasible method for poor ovarian responders undergoing in vitro fertilization/ intracytoplasmic sperm injection-embryo transfer treatment compared to a GnRH antagonist protocol: A retrospective study. Taiwan. J. Obstet. Gynecol. 2016; 55(1): 50-4. http://dx.doi.org/10.1016/j.tjog.2015.07.001.
- Borm G., Mannaerts B. Treatment with the gonadotrophin-releasing hormone antagonist ganirelix in women undergoing ovarian stimulation with recombinant follicle stimulating hormone is effective, safe and convenient: results of a controlled, randomized, multicentre trial. Hum. Reprod. 2000; 15(7): 1490-8. https://dx.doi.org/10.1093/humrep/15.7.1490.
- Messinis I.E. Ovarian feedback, mechanism of action and possible clinical implications. Hum. Reprod. Update. 2006; 12(5): 557-71. https://dx.doi.org/10.1093/humupd/dml020.
- Kuang Y., Chen Q., Fu Y., Wang Y., Hong Q., Lyu Q., Ai A., Shoham Z. Medroxyprogesterone acetate is an effective oral alternative for preventing premature luteinizing hormone surges in women undergoing controlled ovarian hyperstimulation for in vitro fertilization. Fertil. Steril. 2015; 104(1): 62-70. e3. https://dx.doi.org/10.1016/j.fertnstert.2015.03.022